 | |
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C22H29FN4O2 |
| Molar mass | 400.50 g/mol g·mol−1 |
AB-CHFUPYCA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2015.[1] The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but its discovery in recreational drug products suggests that it is intended be a cannabinoid agonist. Although AB-CHFUPYCA contains structural elements common to the synthetic cannabinoid designer drugs AB-PINACA and AB-FUBINACA, it can also be considered an analog of the traditional pyrazole cannabinoid receptor 1 antagonist rimonabant.
See also
- 5F-AB-PINACA
- 5F-ADB
- 5F-AMB
- 5F-APINACA
- AB-FUBINACA
- AB-PINACA
- ADB-CHMINACA
- ADB-FUBINACA
- ADB-PINACA
- ADBICA
- APICA
- APINACA
- MDMB-CHMICA
- Rimonabant
References
- ^ Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1007/s11419-015-0283-8, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with
|doi=10.1007/s11419-015-0283-8instead.